These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 32277669)

  • 1. Prostate 3D ultrasound-guided imaging device (HistoScanning) performance detecting clinically significant prostate cancer.
    Vezelis Alvydas A; Platkevicius G; Kincius KM; Naruseviciute I; Ulys A; Jankevicius F
    J BUON; 2020; 25(1):460-463. PubMed ID: 32277669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanning.
    Simmons LAM; Kanthabalan A; Arya M; Briggs T; Charman SC; Freeman A; Gelister J; Jameson C; McCartan N; Moore CM; van der Muelen J; Emberton M; Ahmed HU
    Prostate Cancer Prostatic Dis; 2019 May; 22(2):261-267. PubMed ID: 30279583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation.
    Simmons LA; Ahmed HU; Moore CM; Punwani S; Freeman A; Hu Y; Barratt D; Charman SC; Van der Meulen J; Emberton M
    Contemp Clin Trials; 2014 Jan; 37(1):69-83. PubMed ID: 24291455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does prostate HistoScanning™ play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies.
    Javed S; Chadwick E; Edwards AA; Beveridge S; Laing R; Bott S; Eden C; Langley S
    BJU Int; 2014 Oct; 114(4):541-8. PubMed ID: 24224648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided transrectal ultrasound: does prostate HistoScanning™ improve detection performance of prostate cancer in repeat biopsies?
    Hamann MF; Hamann C; Trettel A; Jünemann KP; Naumann CM
    BMC Urol; 2015 Jul; 15():76. PubMed ID: 26223353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection, localisation and characterisation of prostate cancer by prostate HistoScanning(™).
    Simmons LA; Autier P; Zát'ura F; Braeckman J; Peltier A; Romic I; Stenzl A; Treurnicht K; Walker T; Nir D; Moore CM; Emberton M
    BJU Int; 2012 Jul; 110(1):28-35. PubMed ID: 22093966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience.
    Sivaraman A; Sanchez-Salas R; Barret E; Macek P; Validire P; Galiano M; Rozet F; Cathelineau X
    World J Urol; 2015 Oct; 33(10):1475-9. PubMed ID: 25501797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Prostate HistoScanning as a Method for Targeted Biopsy in Routine Practice.
    Glybochko PV; Alyaev YG; Amosov AV; Krupinov GE; Nir D; Winkler M; Ganzha TM
    Eur Urol Focus; 2019 Mar; 5(2):179-185. PubMed ID: 28753891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of perineal HistoScanning™ template-guided prostate biopsy].
    Hamann MF; Hamann C; Olzem D; Trettel A; Juenemann KP; Naumann CM
    Urologe A; 2015 Nov; 54(11):1596, 1598-601. PubMed ID: 25794587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
    Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
    J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Diagnostic Accuracy of Biparametric Magnetic Resonance Imaging for Prostate Cancer in Biopsy-Naive Men: The Biparametric MRI for Detection of Prostate Cancer (BIDOC) Study.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Bisbjerg R; Thestrup KC; Winther MD; Jakobsen H; Thomsen HS
    JAMA Netw Open; 2018 Jun; 1(2):e180219. PubMed ID: 30646066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicentre evaluation of targeted and systematic biopsies using magnetic resonance and ultrasound image-fusion guided transperineal prostate biopsy in patients with a previous negative biopsy.
    Hansen NL; Kesch C; Barrett T; Koo B; Radtke JP; Bonekamp D; Schlemmer HP; Warren AY; Wieczorek K; Hohenfellner M; Kastner C; Hadaschik B
    BJU Int; 2017 Nov; 120(5):631-638. PubMed ID: 27862869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
    Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
    J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic Resonance Imaging-guided In-bore and Magnetic Resonance Imaging-transrectal Ultrasound Fusion Targeted Prostate Biopsies: An Adjusted Comparison of Clinically Significant Prostate Cancer Detection Rate.
    Costa DN; Goldberg K; Leon AD; Lotan Y; Xi Y; Aziz M; Freifeld Y; Margulis V; Raj G; Roehrborn CG; Hornberger B; Desai N; Bagrodia A; Francis F; Pedrosa I; Cadeddu JA
    Eur Urol Oncol; 2019 Jul; 2(4):397-404. PubMed ID: 31277776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate histoscanning in clinically localized biopsy proven prostate cancer: an accuracy study.
    Macek P; Barret E; Sanchez-Salas R; Galiano M; Rozet F; Ahallal Y; Gaya JM; Durant M; Mascle L; Giedelman C; Lunelli L; Validire P; Nesvadba M; Cathelineau X
    J Endourol; 2014 Mar; 28(3):371-6. PubMed ID: 24032370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of Transperineal Targeted Prostate Biopsies, Visual Estimation and Image Fusion in Men Needing Repeat Biopsy in the PICTURE Trial.
    Simmons LAM; Kanthabalan A; Arya M; Briggs T; Barratt D; Charman SC; Freeman A; Hawkes D; Hu Y; Jameson C; McCartan N; Moore CM; Punwani S; van der Muelen J; Emberton M; Ahmed HU
    J Urol; 2018 Dec; 200(6):1227-1234. PubMed ID: 30017964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.